
We invest in patient-facing digital health businesses and provider-enabling healthcare IT platforms, with particular expertise at the intersection of the patient and provider experience.
It is our experience that some of the most passionate founders in the Volition portfolio are building in the healthcare industry. Whether motivated by their experiences as a healthcare clinician, by a profound medical event that directly impacted their family, or simply by observing the deep fractures in our current healthcare system, we’ve found that healthcare entrepreneurs bring a unique sense of purpose and fortitude to their endeavors.
It is our privilege to partner with these founders, and our aim is to match the intensity with which they are effecting change in the industry. Our unique, dual focus on digital health and healthcare IT businesses has refined our viewpoint on the intersection of the patient and the provider experience. We are excited to continue investing in companies across all points of the enterprise-facing vs. patient-facing continuum.
The Covid-19 pandemic accelerated many of the core thesis areas that the Volition team had already been pursuing within broader healthcare for many years: increased adoption of telehealth and hybrid care delivery models, heightened focus on enabling access to mental and behavioral health services, mounting healthcare costs leading to a rise in fee-for-performance models, and innovation in clinical platform technologies powering spaces like interoperable electronic health records (EHRs) and remote patient monitoring (RPM) to further break down care silos, to name just a few.
It has been validating to see these themes, which underpinned our investments in companies like Medly and Qure4U, recognize exponentially increasing traction after Covid-19 forced patients and providers alike to transition to virtually-led models of care. While the pandemic was not a catalyst for our firm’s involvement in the healthcare industry – with most of our major holdings pre-dating the start of Covid-19 – our enthusiasm for the space has grown in lockstep with what we view as a foundational shift in perceptions of what truly accessible, convenient, and clinically-forward care looks like today.
We believe that real perspective on the healthcare innovation curve requires a viewpoint on both the patient and the provider experience. At Volition, these cross-functional insights are core to our healthcare team, which encompasses perspectives from the worlds of both digital health and healthcare IT software, allowing us to recognize unique investment opportunities. We believe this is one of the core capabilities that sets apart our approach to underwriting in the healthcare space.
While not exhaustive, we are particularly excited to connect with entrepreneurs and management teams building in the following areas of healthcare:
Our current and exited healthcare portfolio reflects our expertise in areas including digital specialty pharmacy, virtual care platforms, direct-to-consumer healthcare, life sciences supply chain, primary care, health system navigation, and patient engagement.
digital Healthcare Disruption Not long ago, experts predicted that delivery of digital healthcare services via the internet…
The passage of the 21st Century Cures Act, and more recently the implementation of the Final Rule of the Act this past…
Today, we announced the latest of these investments in the internet-enabled services vertical — a $100 million Series B…
Team of second-generation pharmacy owners continues nationwide expansion of digital pharmacy services, with same-day,…
With over $600B of online consumer spend in 2019 driving more than half of retail gains in the U.S., it’s hard to ignore…
Qure4u, the industry leader in digital health, today announced the close of its $25M funding from Boston growth equity firm…
Healthcare IT: What is Revenue Cycle Management? Simply put, Revenue Cycle Management (RCM) relates to everything that has…
The Transition to Digital Healthcare is Just Getting Started with Claude de Jocas The Virtualization of Digital Healthcare…
In the year 2000, there were roughly 2,000 clinical trials being conducted in the United States. Fast forward to 2019, and…
On Thursday we announced a $25M investment in Qure4u, a digital health platform based out of Bradenton, FL. Qure4u is a…
Our initial digital health thesis took a verticalized approach, centered around indiscriminate funding of remote solutions…